Literature DB >> 24281852

Genetic variation in multiple biologic pathways, flavonoid intake, and breast cancer.

Nikhil K Khankari1, Patrick T Bradshaw, Lauren E McCullough, Susan L Teitelbaum, Susan E Steck, Brian N Fink, Xinran Xu, Jiyoung Ahn, Christine B Ambrosone, Katherine D Crew, Mary Beth Terry, Alfred I Neugut, Jia Chen, Regina M Santella, Marilie D Gammon.   

Abstract

PURPOSE: We previously reported an inverse association between flavonoid intake and breast cancer incidence, which has been confirmed by others, but no studies have considered simultaneously potential interactions of flavonoids with multiple genetic polymorphisms involved in biologically relevant pathways (oxidative stress, carcinogen metabolism, DNA repair, and one-carbon metabolism).
METHODS: To estimate interaction effects between flavonoids and 13 polymorphisms in these four pathways on breast cancer risk, we used population-based data (n = 875 cases and 903 controls) and several statistical approaches, including conventional logistic regression and semi-Bayesian hierarchical modeling (incorporating prior information on the possible biologic functions of genes), which also provides biologic pathway-specific effect estimates.
RESULTS: Compared to the standard multivariate model, the results from the hierarchical model indicate that gene-by-flavonoid interaction estimates are attenuated, but more precise. In the hierarchical model, the average effect of the deleterious versus beneficial gene, controlling for average flavonoid intake in the DNA repair pathway, and adjusted for the three other biologically relevant pathways (oxidative stress, carcinogen metabolism, and one-carbon metabolism), resulted in a 27 % increase risk for breast cancer [odds ratio = 1.27; 95 % confidence interval (CI) = 0.70, 2.29]. However, the CI was wide.
CONCLUSIONS: Based on results from the semi-Bayesian model, breast cancer risk may be influenced jointly by flavonoid intake and genes involved in DNA repair, but our findings require confirmation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24281852      PMCID: PMC3932534          DOI: 10.1007/s10552-013-0324-8

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  69 in total

1.  Single nucleotide polymorphisms in the XPG gene: determination of role in DNA repair and breast cancer risk.

Authors:  Rajiv Kumar; Lotta Höglund; Chunyan Zhao; Asta Försti; Erna Snellman; Kari Hemminki
Journal:  Int J Cancer       Date:  2003-02-20       Impact factor: 7.396

2.  DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck.

Authors:  Erich M Sturgis; Kristina R Dahlstrom; Margaret R Spitz; Qingyi Wei
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2002-09

3.  Flavonoid effects relevant to cancer.

Authors:  Delia M Brownson; Nicolas G Azios; Brie K Fuqua; Su F Dharmawardhane; Tom J Mabry
Journal:  J Nutr       Date:  2002-11       Impact factor: 4.798

4.  XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity.

Authors:  Xifeng Wu; Hua Zhao; Qingyi Wei; Christopher I Amos; Kerang Zhang; Zhaozheng Guo; Yawei Qiao; Waun K Hong; Margaret R Spitz
Journal:  Carcinogenesis       Date:  2003-03       Impact factor: 4.944

5.  Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai.

Authors:  Qi Dai; Adrian A Franke; Fan Jin; Xiao-Ou Shu; James R Hebert; Laurie J Custer; Jiarong Cheng; Yu-Tang Gao; Wei Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-09       Impact factor: 4.254

6.  DNA-repair genetic polymorphisms and breast cancer risk.

Authors:  Tasha R Smith; Edward A Levine; Nancy D Perrier; Mark Steven Miller; Rita I Freimanis; Kurt Lohman; L Douglas Case; Jianfeng Xu; Harvey W Mohrenweiser; Jennifer J Hu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-11       Impact factor: 4.254

7.  Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer.

Authors:  Hyo-Sung Jeon; Kyung Mee Kim; Sun Ha Park; Su Yeon Lee; Jin Eun Choi; Ga Young Lee; Sin Kam; Rang Woon Park; In-San Kim; Chang Ho Kim; Tae Hoon Jung; Jae Yong Park
Journal:  Carcinogenesis       Date:  2003-07-17       Impact factor: 4.944

8.  Naturally occurring Phe151Leu substitution near a conserved folding module lowers stability of glutathione transferase P1-1.

Authors:  Henry J Lin; Ann Sofie Johansson; Gun Stenberg; Alicia M Materi; Jae Man Park; Aihua Dai; Haiyan Zhou; Jason S Y Gim; Irving H Kau; Steven I Hardy; Michael W Parker; Bengt Mannervik
Journal:  Biochim Biophys Acta       Date:  2003-06-26

9.  DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer.

Authors:  Benjamin A Rybicki; David V Conti; Andrea Moreira; Mine Cicek; Graham Casey; John S Witte
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-01       Impact factor: 4.254

10.  Flavonoid intake and breast cancer risk: a case--control study in Greece.

Authors:  J Peterson; P Lagiou; E Samoli; A Lagiou; K Katsouyanni; C La Vecchia; J Dwyer; D Trichopoulos
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

View more
  4 in total

1.  Polymorphism of cytosolic serine hydroxymethyltransferase and breast cancer risk: evidence from a meta-analysis.

Authors:  Li Li; Yin Ma; Chaohui Jin; Qianru Zheng; Lin Yang
Journal:  Tumour Biol       Date:  2014-05-01

2.  Flavonoid calycopterin triggers apoptosis in triple-negative and ER-positive human breast cancer cells through activating different patterns of gene expression.

Authors:  Mehrnaz Moradi; Hajar Gholipour; Houri Sepehri; Farnoosh Attari; Ladan Delphi; Ehsan Arefian; Mahdi Moridi Farimani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-07-02       Impact factor: 3.000

3.  Epidemiological Evidences on Dietary Flavonoids and Breast Cancer Risk: A Narrative Review

Authors:  Katrin Sak
Journal:  Asian Pac J Cancer Prev       Date:  2017-09-27

4.  Delphinidin-3-glucoside suppresses breast carcinogenesis by inactivating the Akt/HOTAIR signaling pathway.

Authors:  Xiaohong Yang; En Luo; Xin Liu; Bin Han; Xiaoping Yu; Xiaoli Peng
Journal:  BMC Cancer       Date:  2016-07-07       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.